ÆüËÜÇÀ·Ý²½³Ø²ñ 2022ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

Ÿ¼¨²ñ¡¦µÙ·Æ¼¼ (¥í¥°¥¤¥ó¤¬É¬ÍפǤ¹)
½ªÎ»¤·¤Þ¤·¤¿
¥×¥í¥°¥é¥à½¸PDF ´ë¶ÈÀâÌÀ²ñ
½ªÎ»¤·¤Þ¤·¤¿
¿Ê¹ÔÃæ¤Î¥×¥í¥°¥é¥à°ìÍ÷
½ªÎ»¤·¤Þ¤·¤¿
Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
Âç²ñ¥×¥í¥°¥é¥à½¸¡¦Âç²ñ¹Ö±éÍ׻ݽ¸¡ÎPDF¡Ï¤ÎÊѹ¹ (¹¹¿·¡§3/23)
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge
(Internet Explorer¤ÈSafari¤Ç¤ÏÀµ¤·¤¯É½¼¨¤µ¤ì¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹)

»á̾:EijiOKAMURA ¤Î¸¡º÷·ë²Ì

1 - 1  / 1 <<< 1 >>>

1 - 1  / 1
<<< 1 >>>
2F02-05
2022/03/16 09:30
¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à F
Reveromycin AÀ¸¹çÀ®¹ÚÁÇRevKLM¤Îin sillico²òÀϤˤè¤ëÁê¸ßºîÍÑͽ¬¤È¼Â¸³Åª¸¡¾Ú
Prediction by in sillico analysis and experimental validation of interaction of RevKLM complex for Reveromycin A biosynthesis.
¡û²¬Â¼ ±Ñ¼£1¡¢º´Æ£¡Ê¼®ùõ¡Ë ͵Èþ1¡¢±ü¼ ±ÑÉ×2¡¢·§ºä ¿ò2¡¢Ä¹ÅÄ ÍµÇ·1¡¢¹â¶¶ ½ÓÆó1
¡ûEiji OKAMURA1, Yumi SHIOZAKI-SATO1, Hideo OKUMURA2, Takashi KUMASAKA2, Hiroyuki OSADA1, Shunji TAKAHASHI1
1Íý¸¦ CSRS¡¢2¹âµ±ÅÙ¸÷²Ê³Ø¸¦µæ¥»¥ó¥¿¡¼
1RIKEN CSRS, 2JASRI
1 - 1  / 1 <<< 1 >>>

1 - 1  / 1
<<< 1 >>>